SecSonar.com

LifeMD, Inc. (LFMD)

LifeMD, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

LifeMD, Inc. (LFMD) is a Medical - Pharmaceuticals company based in US with a market capitalization of $214.2M. Revenue declined 8.7% year-over-year and the company generated $6.4M in free cash flow. This page tracks LFMD's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 304 employees · IPO Jan 29, 2008

Valuation

Valuation & price

$4.33 · as of May 17, 2026 · -64.9% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

9.25

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$12.35$7.51$2.67Jul 25Dec 25Jul 26Jul 7, 25$12.20Jul 9, 25$11.78Jul 11, 25$11.26Jul 15, 25$10.94Jul 17, 25$11.10Jul 21, 25$10.42Jul 23, 25$10.85Jul 25, 25$10.69Jul 29, 25$10.20Jul 31, 25$10.41Aug 4, 25$12.35Aug 6, 25$6.53Aug 11, 25$6.72Aug 13, 25$6.89Aug 15, 25$6.43Aug 19, 25$6.11Aug 21, 25$6.29Aug 25, 25$6.19Aug 27, 25$6.41Aug 29, 25$6.19Sep 3, 25$6.10Sep 5, 25$6.06Sep 9, 25$6.08Sep 11, 25$5.89Sep 16, 25$6.01Sep 18, 25$6.43Sep 22, 25$6.55Sep 24, 25$6.40Sep 26, 25$6.43Sep 30, 25$6.79Oct 2, 25$6.92Oct 6, 25$6.94Oct 8, 25$6.64Oct 10, 25$6.17Oct 14, 25$6.35Oct 16, 25$6.43Oct 21, 25$6.17Oct 23, 25$6.23Oct 27, 25$6.14Oct 29, 25$6.12Oct 31, 25$5.91Nov 4, 25$5.42Nov 6, 25$5.26Nov 10, 25$5.13Nov 12, 25$5.07Nov 14, 25$4.63Nov 18, 25$4.09Nov 20, 25$3.71Nov 25, 25$3.93Nov 28, 25$3.83Dec 2, 25$3.56Dec 4, 25$3.73Dec 8, 25$3.64Dec 10, 25$3.61Dec 12, 25$3.40Dec 16, 25$3.42Dec 18, 25$3.24Dec 22, 25$3.20Dec 24, 25$4.00Dec 29, 25$3.44Jan 2, 26$3.49Jan 6, 26$4.22Jan 8, 26$4.00Jan 12, 26$4.19Jan 14, 26$3.85Jan 16, 26$3.77Jan 21, 26$3.54Jan 23, 26$3.58Jan 27, 26$3.50Jan 29, 26$3.37Feb 2, 26$3.28Feb 4, 26$3.07Feb 9, 26$3.20Feb 11, 26$2.91Feb 13, 26$2.78Feb 18, 26$2.95Feb 20, 26$2.82Feb 24, 26$2.67Feb 26, 26$2.78Mar 2, 26$2.91Mar 4, 26$3.12Mar 6, 26$3.00Mar 10, 26$3.91Mar 12, 26$3.94Mar 17, 26$4.44Mar 19, 26$4.09Mar 23, 26$3.98Mar 25, 26$3.90Mar 27, 26$3.72Mar 31, 26$3.61Apr 2, 26$3.51Apr 7, 26$3.43Apr 9, 26$3.40Apr 13, 26$3.91Apr 15, 26$3.83Apr 17, 26$4.09Apr 22, 26$4.62Apr 24, 26$4.64Apr 28, 26$4.55Apr 30, 26$4.68May 4, 26$5.09May 6, 26$5.27May 8, 26$4.78May 12, 26$4.28May 14, 26$4.45May 18, 26$4.24May 20, 26$4.26May 22, 26$4.19May 28, 26$4.59Jun 1, 26$4.63Jun 3, 26$4.56Jun 5, 26$4.89Jun 9, 26$4.82Jun 11, 26$4.90Jun 15, 26$4.91Jun 17, 26$4.91Jun 22, 26$4.31Jun 24, 26$4.50Jun 26, 26$4.13Jul 2, 26$4.93
$2.6452-week range$12.35
Loading valuation history…

Fundamentals

Key fundamentals

$214.2M

Market cap

-8.7%

Revenue growth (YoY)

79.8%

Gross margin

$6.4M

Free cash flow (USD)

-$30.5M

Net debt

Net cash position

9.6%

Share dilution

1/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$5.2MFY 2017$5.1MFY 2018$8.3MFY 2019$12.5MFY 2020$37.3MFY 2021$92.9MFY 2022$119.0MFY 2023$152.5MFY 2024$212.5MFY 2025$194.1M
$5.2M$194.1M

Free cash flow by year

2016 → 2025

FY 2016$-407.9KFY 2017$-817.2KFY 2018$-1.0MFY 2019$251.4KFY 2020$-12.5MFY 2021$-36.5MFY 2022$-35.8MFY 2023$86.9KFY 2024$6.0MFY 2025$6.4M
-$407.9K$6.4M

Gross margin by year

2021 → 2025

FY 202180.6%FY 202284.3%FY 202387.6%FY 202488.7%FY 202579.8%
80.6%79.8%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 6, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventCollaboration AnnouncementJun 22, 2026Filing
  • 8-K eventEarnings ReleaseMay 6, 2026Filing
  • Quarterly report10-Q FiledMay 6, 2026Filing

Questions

Frequently asked questions

What is LifeMD, Inc.'s market cap?

LifeMD, Inc. (LFMD) has a market capitalization of $214.2M.

What is LFMD's P/E ratio?

A meaningful P/E ratio is not available for LFMD — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is LFMD's price-to-book (P/B) ratio?

LFMD trades at 9.25 times book value per share.

Are insiders buying LFMD stock?

SEC Form 4 filings show no open-market insider buys at LifeMD, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Medical - Pharmaceuticals

HITI

High Tide Inc.

$218.4M

YI

111, Inc.

$47.9M

PETS

PetMed Express, Inc.

$46.7M

SDEV

Stablecoin Development Corp.

$35M

NEUP

Neuphoria Therapeutics Inc.

$28.6M

KYNB

Kyntra Bio, Inc.

$28.1M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.